Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Michael Dutro, PharmD
Pfizer
Disclosure(s): Pfizer: Stocks/Bonds (Public Company)
Poster(s):
(P-604)
Preliminary real-world Abrysvo vaccine effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related lower respiratory tract disease (LRTD) hospitalizations and emergency department (ED) visits—Kaiser Permanente of Southern California (KPSC), November 2023-April 2024
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
